Stay updated on SNDX-5613 in R/R Leukemias: Clinical Trial

Sign up to get notified when there's something new on the SNDX-5613 in R/R Leukemias: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SNDX-5613 in R/R Leukemias: Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page footer revision was updated from v3.5.0 to v3.5.3, indicating a site/about-page version display change rather than any modification to the clinical trial information.
    Difference
    0.0%
    Check dated 2026-04-25T18:34:14.000Z thumbnail image
  2. Check
    16 days ago
    No Change Detected
  3. Check
    23 days ago
    Change Detected
    Summary
    Added the March 2026 Mol Cell Proteomics publication 'High-Throughput Proteomic Profiling to Evaluate Differentiation Syndrome With Menin Inhibition' (doi:10.1016/j.mcpro.2026.101522). Removed the January 2026 'Online ahead of print' listing for the same article.
    Difference
    0.0%
    Check dated 2026-04-04T05:44:40.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The study record was updated to add numerous sites and investigators with updated contact details, and several former contacts were removed.
    Difference
    4%
    Check dated 2026-03-20T20:18:29.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Added a new publication citation (Mol Cell Proteomics, 2026) and updated the page revision to v3.4.3; the prior citation was removed (v3.4.2).
    Difference
    0.0%
    Check dated 2026-03-06T18:07:16.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Phase 2 expansion cohorts increased from 3 to 4 with the addition of Cohort 2D (HOX/MEIS upregulation leukemias, including KMT2Ar, NPM1m, and NUP98r) and the enrollment target is updated to 447. Key inclusion/exclusion criteria were added or revised (e.g., CNS prophylaxis allowed, concurrent cytoreductive therapies permitted, and other drug interactions) to reflect new eligibility and concomitant therapy guidelines.
    Difference
    1%
    Check dated 2026-02-20T17:03:13.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The page shows a minor revision update from v3.4.1 to v3.4.2 with no observable changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T12:52:56.000Z thumbnail image

Stay in the know with updates to SNDX-5613 in R/R Leukemias: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SNDX-5613 in R/R Leukemias: Clinical Trial page.